A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take a more proactive approach to prostate cancer screening and care.
|Articles|February 4, 2015
Michelle Gervino Discusses the Benefits of Communicating with Your Nurse
Michelle Gervino, an oncology nurse with John Theurer Cancer Center, advises patients to communicate with their medical team about any side effects they may be experiencing.
Advertisement
Michelle Gervino, an oncology nurse with John Theurer Cancer Center, advises patients to communicate with their medical team about any side effects they may be experiencing.
"You don't want to let any symptom go unchecked. That's why we're here," she says. "As patients, treatments will be better and it will be more manageable" if symptoms are caught early and the medical team has time to alleviate effects, including nausea.
Advertisement
Related to this article
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
A new trial will test whether a set course of Brukinsa plus sonrotoclax, which target two pathways that drive hairy cell leukemia, can offer an alternative to chemotherapy.
Dr. Saum Ghodoussipour of Rutgers Cancer Institute answers top searched bladder cancer questions, from treatment and surgery side effects to sex and work.
Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
Dr. Jacqueline Barrientos shares how a targeted therapy, a determined care team and a stranger’s generosity gave a 72-year-old man with hairy cell leukemia and kidney failure a second chance.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Pancreatic Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
The Breast Cancer Test Many Patients Don’t Know to Ask For
3
Why a Patient With Pancreatic Cancer Moved From Chemotherapy to Rasonque
4
3 Prostate Cancer Results From ESMO 2026 Patients Should Know
5